Put Options

15 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$53.02 - $135.75 $13.5 Million - $34.5 Million
254,400 Added 541.28%
301,400 $16.5 Million
Q2 2022

Aug 12, 2022

SELL
$59.26 - $71.14 $847,418 - $1.02 Million
-14,300 Reduced 23.33%
47,000 $3.11 Million
Q1 2022

May 13, 2022

SELL
$55.72 - $67.12 $317,604 - $382,584
-5,700 Reduced 8.51%
61,300 $4.07 Million
Q4 2021

Feb 11, 2022

SELL
$54.02 - $63.83 $4.98 Million - $5.88 Million
-92,100 Reduced 57.89%
67,000 $3.9 Million
Q3 2021

Nov 12, 2021

BUY
$55.56 - $60.79 $7.54 Million - $8.25 Million
135,700 Added 579.91%
159,100 $9.56 Million
Q2 2021

Aug 13, 2021

SELL
$48.42 - $60.18 $1.84 Million - $2.29 Million
-38,000 Reduced 61.89%
23,400 $1.4 Million
Q1 2021

May 14, 2021

BUY
$47.16 - $54.44 $2.66 Million - $3.07 Million
56,400 Added 1128.0%
61,400 $3.05 Million
Q2 2020

Aug 14, 2020

BUY
$43.1 - $55.31 $64,650 - $82,965
1,500 Added 42.86%
5,000 $264,000
Q1 2020

May 14, 2020

SELL
$37.79 - $51.33 $2.98 Million - $4.04 Million
-78,800 Reduced 95.75%
3,500 $156,000
Q4 2019

Feb 13, 2020

SELL
$42.46 - $50.46 $3.52 Million - $4.19 Million
-83,000 Reduced 50.21%
82,300 $4.1 Million
Q3 2019

Nov 08, 2019

BUY
$40.12 - $45.47 $1.64 Million - $1.86 Million
40,800 Added 32.77%
165,300 $7.37 Million
Q2 2019

Aug 14, 2019

SELL
$37.28 - $41.68 $100,656 - $112,536
-2,700 Reduced 2.12%
124,500 $5.14 Million
Q1 2019

May 15, 2019

SELL
$35.49 - $43.02 $3.53 Million - $4.28 Million
-99,600 Reduced 43.92%
127,200 $5.14 Million
Q4 2018

Feb 13, 2019

BUY
$36.86 - $41.49 $3.55 Million - $4 Million
96,400 Added 73.93%
226,800 $8.61 Million
Q3 2018

Nov 13, 2018

BUY
$34.76 - $39.72 $4.53 Million - $5.18 Million
130,400 New
130,400 $5.16 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $233B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.